Lopez G, Salas CA, Cadiz F, et al. - Researchers focussed on the use of complementary and integrative medicine (CIM) approaches by oncology patients in Chile and South America. At the Clinica Alemana in Santiago, Chile, they identified 432 patients for the survey; of these, 66.9% were diagnosed with breast cancer; 84.8% were women; the majority of patients (58.1%) were between age 40 and 60 years; 51.5% (n = 221) reported CIM use. CIM use was not identified to be associated with the sociodemographic variables of gender, age, education, or income. In all, CIM use was reported in 44.6% of patients with breast cancer vs 64.8% of patients with other cancer types. Herbals (49.1%), vitamins and minerals (40.8%), and prayer or meditation (40.4%) were the most commonly reported types of CIM used. For CIM use, the most frequent reasons were to “do everything possible” (72%) and to “improve my immune function” (67.8%). CIM was initiated by most patients (43.4%) at the time of cancer diagnosis, with only 55.4% sharing information regarding CIM use with their medical team. To increase communication regarding this subject and contribute to improved outcomes, they suggest enhancing awareness of regional differences in CIM use.